Sweden
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.36 B
|
Dec. 31, 2023 | USD 26.00 | 1.16% |
|
Sweden |
|
2 |
USD 474.75 M
|
Dec. 31, 2023 | USD 28.08 | 0.23% |
|
Sweden |
|
3 |
USD 401.22 M
|
Dec. 31, 2023 | USD 28.64 | 0.87% |
|
Sweden |
|
4 |
USD 378.61 M
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
5 |
USD 195.03 M
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
6 |
USD 89.13 M
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
7 |
USD 82.78 M
|
Dec. 31, 2023 | USD 17.18 | 2.59% |
|
Sweden |
|
8 |
USD 67.71 M
|
Dec. 31, 2023 | USD 4.73 | 3.81% |
|
Sweden |
|
9 |
USD 64.02 M
|
Dec. 31, 2023 | USD 8.02 | 0.46% |
|
Sweden |
|
10 |
USD 61.88 M
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
11 |
USD 54.35 M
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
12 |
USD 47.80 M
|
Dec. 31, 2023 | USD 3.41 | 3.24% |
|
Sweden |
|
13 |
USD 46.79 M
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
14 |
USD 46.35 M
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
15 |
USD 33.36 M
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
16 |
USD 31.39 M
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
17 |
USD 27.33 M
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
18 |
USD 24.91 M
|
Dec. 31, 2023 | USD 52.21 | -0.68% |
|
Sweden |
|
19 |
USD 17.20 M
|
Dec. 31, 2023 | USD 3.87 | 2.52% |
|
Sweden |
|
20 |
USD 17.10 M
|
Dec. 31, 2023 | USD 14.61 | 2.17% |
|
Sweden |
|
21 |
USD 16.53 M
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
22 |
USD 11.82 M
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
23 |
USD 7.28 M
|
Dec. 31, 2023 | USD 2.97 | 0.98% |
|
Sweden |
|
24 |
USD 5.41 M
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
25 |
USD 4.96 M
|
Dec. 31, 2023 | USD 42.37 | 0.78% |
|
Sweden |
|
26 |
USD 4.86 M
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
27 |
USD 4.37 M
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
28 |
USD 4.11 M
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
29 |
USD 4.08 M
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
30 |
USD 1.92 M
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
31 |
USD 1.86 M
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
32 |
USD 1.81 M
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
33 |
USD 596.95 K
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
34 |
USD 446.52 K
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
35 |
USD 114.99 K
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
36 |
USD 102.25 K
|
Dec. 31, 2023 | USD 0.12 | 3.82% |
|
Sweden |
|
37 |
USD 61.19 K
|
Dec. 31, 2023 | USD 0.23 | -0.87% |
|
Sweden |
|
38 |
USD -43.72 K
|
Dec. 31, 2023 | USD 0.78 | 5.47% |
|
Sweden |
|
39 |
USD -175.98 K
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
40 |
USD -224.74 K
|
Dec. 31, 2023 | USD 0.28 | 6.05% |
|
Sweden |
|
41 |
USD -249.41 K
|
Dec. 31, 2023 | USD 0.14 | 1.34% |
|
Sweden |
|
42 |
USD -293.69 K
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
43 |
USD -312.39 K
|
Dec. 31, 2023 | USD 1.35 | -1.92% |
|
Sweden |
|
44 |
USD -770.06 K
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
45 |
USD -976.14 K
|
Dec. 31, 2023 | USD 0.39 | 2.53% |
|
Sweden |
|
46 |
USD -996.97 K
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
47 |
USD -1.21 M
|
April 30, 2024 | USD 0.14 | 0.68% |
|
Sweden |
|
48 |
USD -1.31 M
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
49 |
USD -1.36 M
|
Aug. 31, 2024 | USD 0.30 | -1.39% |
|
Sweden |
|
50 |
USD -1.57 M
|
Dec. 31, 2023 | USD 0.45 | 23.08% |
|
Sweden |
The Pharmaceuticals company in Sweden with the highest EBIT is Essity AB (publ) (Stockholm Stock Exchange: ESSITY-B.ST) at USD 1.36 B.
The Pharmaceuticals company in Sweden with the lowest EBIT is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -356.31 M.
The top 10 Pharmaceuticals companies in Sweden by EBIT are Essity AB (publ), Lifco AB (publ), Swedish Orphan Biovitrum AB (publ), Getinge AB (publ), Elekta AB (publ), Arjo AB (publ), Medicover AB (publ), Nolato AB (publ), Linc AB and AddLife AB (publ).
The bottom 10 Pharmaceuticals companies in Sweden by EBIT are Vitrolife AB (publ), Hansa Biopharma AB (publ), BioInvent International AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, Xspray Pharma AB (publ) and IRLAB Therapeutics AB (publ).